undefined Publications

Celastrol alleviated acute kidney injury by inhibition of ferroptosis through Nrf2/GPX4 pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 25, 2023

Correction: FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation.

Journal: Cell death & disease

Published: April 19, 2023

rFGF4 alleviates lipopolysaccharide-induced acute lung injury by inhibiting the TLR4/NF-κB signaling pathway.

Journal: International immunopharmacology

Published: November 22, 2022

PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1ΔHBS in Chronic Kidney Diseases via Inhibition of TGF-β1/SMAD3 Signaling.

Journal: Frontiers in pharmacology

Published: April 03, 2021

Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 04, 2020

Sustained remission of type 2 diabetes in rodents by centrally administered fibroblast growth factor 4.

Journal: Cell metabolism

Published: October 28, 2020

FGF1ΔHBS prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression.

Journal: Signal transduction and targeted therapy

Published: September 02, 2020

PDE1 or PDE5 inhibition augments NO-dependent hypoxic constriction of porcine coronary artery via elevating inosine 3',5'-cyclic monophosphate level.

Journal: Journal of cellular and molecular medicine

Published: April 18, 2020

FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation.

Journal: Cell death & disease

Published: January 31, 2019

Expression and activity analysis of β Gallinacin-3 in Arabidopsis.

Journal: Protein expression and purification

Published: July 16, 2017

Highly efficient production of functional recombinant human fibroblast growth factor 22 in E. coli and its protective effects on H2O2-lesioned L02 cells.

Journal: Protein expression and purification

Published: December 20, 2016

High production in E. coli of biologically active recombinant human fibroblast growth factor 20 and its neuroprotective effects.

Journal: Applied microbiology and biotechnology

Published: October 22, 2015

Dezhong Wang

Celastrol alleviated acute kidney injury by inhibition of ferroptosis through Nrf2/GPX4 pathway.

Celastrol alleviated acute kidney injury by inhibition of ferroptosis through Nrf2/GPX4 pathway.

Correction: FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation.

Correction: FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation.

rFGF4 alleviates lipopolysaccharide-induced acute lung injury by inhibiting the TLR4/NF-κB signaling pathway.

rFGF4 alleviates lipopolysaccharide-induced acute lung injury by inhibiting the TLR4/NF-κB signaling pathway.

PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1ΔHBS in Chronic Kidney Diseases via Inhibition of TGF-β1/SMAD3 Signaling.

PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1ΔHBS in Chronic Kidney Diseases via Inhibition of TGF-β1/SMAD3 Signaling.

Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability.

Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability.

Sustained remission of type 2 diabetes in rodents by centrally administered fibroblast growth factor 4.

Sustained remission of type 2 diabetes in rodents by centrally administered fibroblast growth factor 4.

FGF1ΔHBS prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression.

FGF1ΔHBS prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression.

PDE1 or PDE5 inhibition augments NO-dependent hypoxic constriction of porcine coronary artery via elevating inosine 3',5'-cyclic monophosphate level.

PDE1 or PDE5 inhibition augments NO-dependent hypoxic constriction of porcine coronary artery via elevating inosine 3',5'-cyclic monophosphate level.

FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation.

FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation.

Expression and activity analysis of β Gallinacin-3 in Arabidopsis.

Expression and activity analysis of β Gallinacin-3 in Arabidopsis.

Highly efficient production of functional recombinant human fibroblast growth factor 22 in E. coli and its protective effects on H2O2-lesioned L02 cells.

Highly efficient production of functional recombinant human fibroblast growth factor 22 in E. coli and its protective effects on H2O2-lesioned L02 cells.

High production in E. coli of biologically active recombinant human fibroblast growth factor 20 and its neuroprotective effects.

High production in E. coli of biologically active recombinant human fibroblast growth factor 20 and its neuroprotective effects.

Highly efficient production of functional recombinant human fibroblast growth factor 22 in E. coli and its protective effects on H2O2-lesioned L02 cells.

Highly efficient production of functional recombinant human fibroblast growth factor 22 in E. coli and its protective effects on H2O2-lesioned L02 cells.